The program, available to patients of any age in the United States and Canada who have a pancreatic adenocarcinoma or pancreatic neuroendocrine tumor, was created to address barriers to testing for patients who do not or cannot rely on insurance coverage, according to the company. Read more . . .
Medical genetics company Invitae is offering genetic testing and counseling to patients with pancreatic cancer free of charge via its Detect Hereditary Pancreatic Cancer testing program.